Stocks
Bio-Rad Laboratories (BIO) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -0.32 | 0.09 | 0.31 | 0.14 | -0.02 | -5.39 | |||
| Changes by years, y/y, % | +178% | -128% | +243% | -56% | -118% | -33.7% | |||
Bio-Rad Laboratories. Debt/EBITDA
Bio-Rad Laboratories. Debt/EBITDA, changes, %
Bio-Rad Laboratories (BIO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.12 | 0.05 | 0.22 | -0.01 | -5.39 | -5.39 | ||
| Changes by years, y/y, % | -91% | -68% | -29% | -110% | -4 766% | |||
| Changes by quarters, q/q, % | -16% | -59% | +357% | -106% | +38 857% | |||
